Short Interest in Huron Consulting Group Inc. (NASDAQ:HURN) Increases By 29.6%

Huron Consulting Group Inc. (NASDAQ:HURN - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 483,000 shares, a growth of 29.6% from the March 15th total of 372,700 shares. Based on an average trading volume of 202,000 shares, the days-to-cover ratio is presently 2.4 days. Approximately 2.8% of the shares of the stock are sold short.

Analyst Ratings Changes

A number of brokerages have recently commented on HURN. Barrington Research reissued an "outperform" rating and set a $167.00 price target on shares of Huron Consulting Group in a research note on Thursday, March 27th. Truist Financial lifted their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research report on Tuesday, March 4th. Benchmark restated a "buy" rating and issued a $165.00 price target on shares of Huron Consulting Group in a research report on Wednesday, March 26th. William Blair reaffirmed an "outperform" rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Finally, Wedbush boosted their price objective on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 26th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $169.25.

Huron Consulting Group Trading Down 0.9 %

Shares of NASDAQ HURN traded down $1.20 during midday trading on Thursday, reaching $136.01. The stock had a trading volume of 21,477 shares, compared to its average volume of 145,388. Huron Consulting Group has a twelve month low of $84.26 and a twelve month high of $153.85. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The company's 50 day moving average price is $141.69 and its 200 day moving average price is $128.14. The firm has a market cap of $2.44 billion, a price-to-earnings ratio of 29.56 and a beta of 0.37.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last released its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $399.31 million for the quarter, compared to analyst estimates of $380.62 million. As a group, sell-side analysts expect that Huron Consulting Group will post 6.1 EPS for the current year.

Insider Transactions at Huron Consulting Group

In other news, Director James H. Roth sold 8,641 shares of the company's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $142.38, for a total transaction of $1,230,305.58. Following the completion of the transaction, the director now directly owns 47,638 shares in the company, valued at approximately $6,782,698.44. This represents a 15.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John Mccartney sold 500 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $151.13, for a total value of $75,565.00. Following the completion of the transaction, the director now owns 55,688 shares of the company's stock, valued at $8,416,127.44. The trade was a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 78,781 shares of company stock valued at $11,484,452. 2.15% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Huron Consulting Group

Several institutional investors and hedge funds have recently made changes to their positions in HURN. Dakota Wealth Management lifted its stake in Huron Consulting Group by 4.0% in the fourth quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider's stock valued at $280,000 after buying an additional 87 shares during the period. Summit Investment Advisors Inc. lifted its position in shares of Huron Consulting Group by 5.5% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider's stock valued at $228,000 after acquiring an additional 96 shares during the period. Andina Capital Management LLC boosted its stake in Huron Consulting Group by 3.4% during the fourth quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider's stock worth $410,000 after acquiring an additional 107 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in Huron Consulting Group by 3.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,039 shares of the business services provider's stock worth $502,000 after purchasing an additional 121 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in Huron Consulting Group by 27.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after purchasing an additional 122 shares in the last quarter. Institutional investors own 93.90% of the company's stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.